These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Three unreported glucokinase (GCK) missense mutations detected in the screening of thirty-two Brazilian kindreds for GCK and HNF1A-MODY. Weinert LS; Silveiro SP; Giuffrida FM; Cunha VT; Bulcão C; Calliari LE; Della Manna T; Kunii IS; Dotto RP; Dias-da-Silva MR; Reis AF Diabetes Res Clin Pract; 2014 Nov; 106(2):e44-8. PubMed ID: 25174781 [TBL] [Abstract][Full Text] [Related]
83. Low prevalence of MODY2 and MODY3 mutations in Brazilian individuals with clinical MODY phenotype. Furuzawa GK; Giuffrida FM; Oliveira CS; Chacra AR; Dib SA; Reis AF Diabetes Res Clin Pract; 2008 Sep; 81(3):e12-4. PubMed ID: 18672310 [TBL] [Abstract][Full Text] [Related]
84. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Velho G; Blanché H; Vaxillaire M; Bellanné-Chantelot C; Pardini VC; Timsit J; Passa P; Deschamps I; Robert JJ; Weber IT; Marotta D; Pilkis SJ; Lipkind GM; Bell GI; Froguel P Diabetologia; 1997 Feb; 40(2):217-24. PubMed ID: 9049484 [TBL] [Abstract][Full Text] [Related]
85. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Gloyn AL Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946 [TBL] [Abstract][Full Text] [Related]
86. [Glucokinase gene abnormalities in maturity-onset diabetes of the young (MODY) and late-onset NIDDM]. Odawara M Nihon Rinsho; 1994 Oct; 52(10):2580-6. PubMed ID: 7983782 [TBL] [Abstract][Full Text] [Related]
87. Glucokinase MODY and implications for treatment goals of common forms of diabetes. Ajjan RA; Owen KR Curr Diab Rep; 2014 Dec; 14(12):559. PubMed ID: 25344793 [TBL] [Abstract][Full Text] [Related]
88. Glucokinase and MODY: from the gene to the disease. Froguel P Diabet Med; 1996 Sep; 13(9 Suppl 6):S96-7. PubMed ID: 8894491 [No Abstract] [Full Text] [Related]
89. A novel glucokinase deletion (p.Lys32del) and five previously described mutations co-segregate with the phenotype of mild familial hyperglycaemia (MODY2) in Brazilian families. Giuffrida FM; Calliari LE; Manna TD; Ferreira JG; Saddi-Rosa P; Kunii IS; Furuzawa GK; Dias-da-Silva MR; Reis AF Diabetes Res Clin Pract; 2013 May; 100(2):e42-5. PubMed ID: 23433541 [TBL] [Abstract][Full Text] [Related]
90. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs. Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519 [TBL] [Abstract][Full Text] [Related]
91. GCK mutations in Chinese MODY2 patients: a family pedigree report and review of Chinese literature. Ping Xiao Y; Hua Xu X; Lan Fang Y; Jiang L; Chen C; Liang L; Lin Wang C J Pediatr Endocrinol Metab; 2016 Aug; 29(8):959-64. PubMed ID: 27269892 [TBL] [Abstract][Full Text] [Related]